ENTRY       D12427                      Drug
NAME        Latozinemab (USAN/INN)
FORMULA     C6484H10078N1720O2037S42
EXACT_MASS  145974.616
MOL_WEIGHT  146064.4299
SEQUENCE    (Heavy chain)
            QVQLQESGPG LVKPSETLSL TCAVSGYSIS SGYYWGWIRQ PPGKGLEWIG TIYHSGSTYY
            NPSLKSRVTI SVDTSKNQFS LKLSSVTAAD TAVYYCARQG SIKQGYYGMD VWGQGTTVTV
            SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
            SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKKV EPKSCDKTHT CPPCPAPEAA
            GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ
            YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPASIEKT ISKAKGQPRE PQVYTLPPSR
            DELTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS
            RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
            (Light chain)
            DIVMTQSPLS LPVTPGEPAS ISCRSSQSLL RSTGYNYLDW YLQKPGQSPQ LLIYLGSNRA
            SGVPDRFSGS GSGTDFTLKI SRAEAEDVGV YYCMQQQEAP LTFGGGTKVE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (Disulfide bridge: H22-H96, H149-H205, H225-L219, H231-H'231, H234-H'234, H266-H326, H372-H430, H'22-H'96, H'149-H'205, H'225-L'219, H'266-H'326, H'372-H'430, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  TYPE      Peptide
EFFICACY    Dementia therapeutic agent
  TYPE      Monoclonal antibody
COMMENT     Treatment of dementia
TARGET      SORT1 [HSA:6272] [KO:K12388]
  PATHWAY   hsa04722(6272)  Neurotrophin signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Cellular process
               Membrane trafficking
                SORT1
                 D12427  Latozinemab (USAN/INN)
DBLINKS     CAS: 2376132-27-1
///
